An Open-label Multicenter Phase 1b Study of JNJ-63723283 a PD-1 Inhibitor Administered in Combination with Apalutamide in Subjects with Metastatic Castration-Resistant Prostate Cancer
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
